1. Home
  2. BCV vs STIM Comparison

BCV vs STIM Comparison

Compare BCV & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bancroft Fund Ltd.

BCV

Bancroft Fund Ltd.

HOLD

Current Price

$23.80

Market Cap

129.4M

Sector

Finance

ML Signal

HOLD

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$2.20

Market Cap

105.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCV
STIM
Founded
1971
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
129.4M
105.5M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
BCV
STIM
Price
$23.80
$2.20
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
26.3K
1.4M
Earning Date
01-01-0001
03-03-2026
Dividend Yield
8.13%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$129,873,000.00
Revenue This Year
N/A
$101.67
Revenue Next Year
N/A
$10.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
78.61
52 Week Low
$14.09
$1.25
52 Week High
$18.11
$5.92

Technical Indicators

Market Signals
Indicator
BCV
STIM
Relative Strength Index (RSI) 71.41 68.10
Support Level $23.40 $1.73
Resistance Level $23.89 $2.13
Average True Range (ATR) 0.33 0.20
MACD 0.11 0.05
Stochastic Oscillator 96.16 96.11

Price Performance

Historical Comparison
BCV
STIM

About BCV Bancroft Fund Ltd.

Bancroft Fund Ltd is a diversified closed-end management company. It operates as a closed-ended equity mutual fund. The funds' main objective is to provide income and potential for capital appreciation. With the intent to achieve its objective, the company invests in convertible and equity securities. It invests across different industries such as Computer Software and Services, Energy and Utilities, Health Care among others.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Share on Social Networks: